| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8485528 | Vaccine | 2018 | 10 Pages |
Abstract
The adjuvant 7.5â¯Î¼g booster and 60â¯Î¼g single vaccine strategies provided better seroconversion and seroprotection outcomes. These findings have important implications for national and international guidelines for influenza vaccination for HIV-positive people and future research.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Wei Zhang, Huiying Sun, Mohammad Atiquzzaman, Julie Sou, Aslam H. Anis, Curtis Cooper,